Penn, CHOP researchers call leukemia study 'unprecedented'

An experimental cellular therapy for leukemia developed at the Perelman School of Medicine at the University of Pennsylvania achieved complete remission in 90 percent of its clinical study patients...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.